PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9715947::ACT054546

HAZ

Evidence text

Paper-level observation

Section 3.5: HAZ displayed potent antiproliferative effects on A549 cells, with an IC50 around 5.44 µM.
textConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
other
Comparator
=
Raw observation
5.44 µM
Normalized measurement
=5.44 µM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
GVKFAKRFWRFAKKAFKRFEK
Standardization
ready simple

Source publication

HAZ, a novel peptide with broad-spectrum antibacterial activity

Saudi Pharmaceutical Journal · 2022

DOI 10.1016/j.jsps.2022.09.009 PMC9715947
Parent mention

Related peptide identities

PEPDIA-PLP-001133

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.